Estimated Revenue: $1M to $10M
Funding Status: IPO
Headquarters: Hayward, California, United States
Total Funding: $226.7M
Investors Number: 17
Number Of Exists: N/A
Founded Date: 2015
Technology: Anti-infective Drugs
Industry: PharmTech
Last Funding Type: Series C
Investor Type: N/A
Investment Stage: N/A
Employee Number: 101-250